Azathioprine and subacute myelomonocytic leukemia.
The occurrence of subacute myelomonocytic leukemia is reported in a patient who had been treated with azathioprine for six years because of systemic lupus erythematosus. A review of the literature yielded 16 additional patients with non-lymphocytic leukemia after the use of azathioprine.
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects*; D001853:Bone Marrow / Q000473:pathology; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy
D001379:Azathioprine